Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy
- PMID: 34635856
- DOI: 10.1038/s41591-021-01526-z
Reply to: Caution at psychiatry's psychedelic frontier and Challenges with benchmarking of MDMA-assisted psychotherapy
Comment on
-
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10. Nat Med. 2021. PMID: 33972795 Free PMC article. Clinical Trial.
-
Challenges with benchmarking of MDMA-assisted psychotherapy.Nat Med. 2021 Oct;27(10):1689-1690. doi: 10.1038/s41591-021-01525-0. Epub 2021 Oct 11. Nat Med. 2021. PMID: 34635857 No abstract available.
-
Caution at psychiatry's psychedelic frontier.Nat Med. 2021 Oct;27(10):1687-1688. doi: 10.1038/s41591-021-01524-1. Epub 2021 Oct 11. Nat Med. 2021. PMID: 34635858 No abstract available.
Similar articles
-
Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.J Acad Consult Liaison Psychiatry. 2021 Jul-Aug;62(4):460-471. doi: 10.1016/j.jaclp.2020.12.011. Epub 2021 Jan 21. J Acad Consult Liaison Psychiatry. 2021. PMID: 34210406
-
Caution at psychiatry's psychedelic frontier.Nat Med. 2021 Oct;27(10):1687-1688. doi: 10.1038/s41591-021-01524-1. Epub 2021 Oct 11. Nat Med. 2021. PMID: 34635858 No abstract available.
-
Challenges with benchmarking of MDMA-assisted psychotherapy.Nat Med. 2021 Oct;27(10):1689-1690. doi: 10.1038/s41591-021-01525-0. Epub 2021 Oct 11. Nat Med. 2021. PMID: 34635857 No abstract available.
-
Compassionate use of psychedelics.Med Health Care Philos. 2020 Sep;23(3):485-496. doi: 10.1007/s11019-020-09958-z. Med Health Care Philos. 2020. PMID: 32468195 Review.
-
Why MDMA therapy for alcohol use disorder? And why now?Neuropharmacology. 2018 Nov;142:83-88. doi: 10.1016/j.neuropharm.2017.11.004. Epub 2017 Nov 7. Neuropharmacology. 2018. PMID: 29126911 Review.
Cited by
-
If psychedelics heal, how do they do it?Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2321906121. doi: 10.1073/pnas.2321906121. Epub 2024 Jan 3. Proc Natl Acad Sci U S A. 2024. PMID: 38170743 Free PMC article. No abstract available.
-
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations.Eur Child Adolesc Psychiatry. 2023 Oct 10. doi: 10.1007/s00787-023-02310-9. Online ahead of print. Eur Child Adolesc Psychiatry. 2023. PMID: 37814082 Review.
-
MDMA-Assisted Psychotherapy for Borderline Personality Disorder.Focus (Am Psychiatr Publ). 2022 Oct;20(4):358-367. doi: 10.1176/appi.focus.20220056. Epub 2022 Oct 25. Focus (Am Psychiatr Publ). 2022. PMID: 37200873 Free PMC article. Review.
-
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.Ir J Med Sci. 2022 Jun;191(3):1385-1397. doi: 10.1007/s11845-021-02668-2. Epub 2021 Jun 15. Ir J Med Sci. 2022. PMID: 34131812 Free PMC article.
References
-
- Mitchell, J. M. et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. https://doi.org/10.1038/s41591-021-01336-3 (2021).
-
- Halvorsen, J. Ø. et. al. Nat. Med. doi (2021).
-
- Burke, M. J. et. al. Nat. Med. doi (2021).
-
- Feduccia, A. A. et al. Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline. Front. Psychiatry September 2019, 1–7 (2019).
-
- Jerome, L. et al. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Psychopharmacol. 237, 2485–2497 (2020). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical